SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.
Contract Category
4 federal contract opportunities classified as Pharmaceutical Ingredients.
AI Summary
The Defense Logistics Agency (DLA) is seeking information on the country of origin and active pharmaceutical ingredient sourcing for generic pharmaceutical products. This RFI aims to gather industry data for proposed legislation regarding supply chain transparency and labeling requirements. Responses should include det…
PA
AI Summary
The National Institutes of Health is seeking quotations for specific chemical supplies, including (1R,2R)-trans-N-Boc-1,2 cyclopentanediamine and related products. This opportunity is a sole source procurement with Cyclope Bio SL, emphasizing the need for high purity and specific enantiomeric excess. Quotations are due…
MD
AI Summary
The Department of Defense, Defense Logistics Agency, has issued a contract opportunity for Alfuzosin HCL. The contract, with a modification number of P00004, invokes Option 3 for the period from March 18, 2022, to March 17, 2023. Additionally, modification P00003 invokes Option 2 for the period from March 18, 2021, to …
PA
AI Summary
The Department of Defense, specifically the Defense Logistics Agency, has issued a solicitation for Ibandronate Sodium. The contract opportunity, with a closing date of October 24, 2020, seeks potential bidders to provide Ibandronate Sodium. Interested parties should refer to the solicitation number SPE2D2-20-R-0074 fo…
PA
Common questions about finding and winning Pharmaceutical Ingredients government contracts.